SCHEMBL21846187

SCHEMBL21846187

C=C1CCC[C@@H]1COc1nc(CC)c(CCC)c(N(CCC)C[C@@H](C)CC#N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21846280 0.84 — —
SCHEMBL21846435 0.79 — —
SCHEMBL21846275 0.77 — —
SCHEMBL25020089 0.75 — —
SCHEMBL25020009 0.73 — —
SCHEMBL21846281 0.73 — —
SCHEMBL25021051 0.73 KDM4E (0.30) —
SCHEMBL21912368 0.71 — —
SCHEMBL21895575 0.67 — —
SCHEMBL25021610 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055760-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback